Carola Gianni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carola Gianni has a total of 372 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Natale
Texas Cardiac Arrhythmia Institute, St. David’s Medical Center, Austin (S.M., A.N.).
71 shared publications - Domenico Giovanni Della Rocca
Heart Rhythm Management Centre, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel , Brussels
48 shared publications - Amin Al-Ahmad
Texas Cardiac Arrhythmia Research Foundation, Austin, Texas, USA
42 shared publications - Luigi Di Biase
Montefiore Einstein Center for Heart and Vascular Care, Montefiore Medical Center , Bronx, NY, 10467
42 shared publications Sanghamitra Mohanty
39 shared publications- Sanghamitra Mohanty
Texas Cardiac Arrhythmia Institute, St. David’s Medical Center, Austin (S.M., A.N.).
26 shared publications
Latest Publications
- 22 May 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (9) , 2159-2169
High-Voltage Pulsed Field Ablation
- 22 May 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (9) , 2159-2169
High-Voltage Pulsed Field Ablation
- 3 March 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (4) , 876-878
Early vs Very Late Recurrence of Ventricular Tachycardia in Dilated Cardiomyopathy
- 3 March 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (4) , 876-878
Early vs Very Late Recurrence of Ventricular Tachycardia in Dilated Cardiomyopathy
- 8 January 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (3) , 638-642
Passive Right Atrial Activation Driven by the Coronary Sinus Fibrillatory Activity
- 8 January 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (3) , 638-642
Passive Right Atrial Activation Driven by the Coronary Sinus Fibrillatory Activity
- 1 December 2025
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (12) , e014021
Pulsed Field Ablation–Related Hemolysis: Comparison Between Technologies
BACKGROUND: Hemolysis is a recognized side effect of pulsed field ablation (PFA). Severe hemolysis can lead to acute kidney injury, affecting the morbidity of patients undergoing PFA for atrial fibrillation. Here, we aimed to characterize the degree of hemolysis across different PFA technologies. METHODS: This is a retrospective cohort study of 552 PFA procedures performed in our center, where Hp (haptoglobin) was measured both at baseline and on postoperative day 1. The PFA catheters used were Farawave (59%), Sphere-9 (19%), Pulseselect (16%), and Varipulse (5.8%). RESULTS: Hemolysis (ie, reduction in Hp >10 mg/dL) was observed in the majority of cases (95%), with the lowest incidence observed in patients undergoing PFA with Sphere-9 (88%) compared with Farawave (97%), Varipulse (97%), and Pulseselect (100%). Significant and severe hemolysis (ie, Hp–postoperative day 1 ≤25 mg/mL and Hp–postoperative day 1 ≤10 mg/mL) occurred in 34% and 13%, with a different distribution across catheter types: Farawave 46% and 21%, Varipulse 29% and 9.7%, Pulseselect 23% and 1.2%, and Sphere-9 5.5% and 0%. Hp decreased by a mean of 76±40 mg/dL from baseline, with a significantly greater degree of reduction seen with Farawave (94±40 mg/dL) and Varipulse (85±32 mg/dL) compared with Pulseselect (62±25 mg/dL) or Sphere-9 (39±23 mg/dL). There is a linear relationship between Hp reduction and number of PFA applications, with a decrease of Hp per application of 0.47 mg/dL (95% CI, 0.22–0.71 mg/dL) for Farawave, 0.40 mg/dL (95% CI, 0.09–0.73 mg/dL) for Pulseselect, and 0.10 mg/dL (95% CI, 0.02–0.19 mg/dL) for Sphere-9. CONCLUSIONS: PFA-induced hemolysis is common, with different PFA technologies exhibiting variable degrees of hemolysis, lower with the focal PFA catheter Sphere-9 when compared with single-shot PFA catheters.
- 1 December 2025
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (12) , e014021
Pulsed Field Ablation–Related Hemolysis: Comparison Between Technologies
BACKGROUND: Hemolysis is a recognized side effect of pulsed field ablation (PFA). Severe hemolysis can lead to acute kidney injury, affecting the morbidity of patients undergoing PFA for atrial fibrillation. Here, we aimed to characterize the degree of hemolysis across different PFA technologies. METHODS: This is a retrospective cohort study of 552 PFA procedures performed in our center, where Hp (haptoglobin) was measured both at baseline and on postoperative day 1. The PFA catheters used were Farawave (59%), Sphere-9 (19%), Pulseselect (16%), and Varipulse (5.8%). RESULTS: Hemolysis (ie, reduction in Hp >10 mg/dL) was observed in the majority of cases (95%), with the lowest incidence observed in patients undergoing PFA with Sphere-9 (88%) compared with Farawave (97%), Varipulse (97%), and Pulseselect (100%). Significant and severe hemolysis (ie, Hp–postoperative day 1 ≤25 mg/mL and Hp–postoperative day 1 ≤10 mg/mL) occurred in 34% and 13%, with a different distribution across catheter types: Farawave 46% and 21%, Varipulse 29% and 9.7%, Pulseselect 23% and 1.2%, and Sphere-9 5.5% and 0%. Hp decreased by a mean of 76±40 mg/dL from baseline, with a significantly greater degree of reduction seen with Farawave (94±40 mg/dL) and Varipulse (85±32 mg/dL) compared with Pulseselect (62±25 mg/dL) or Sphere-9 (39±23 mg/dL). There is a linear relationship between Hp reduction and number of PFA applications, with a decrease of Hp per application of 0.47 mg/dL (95% CI, 0.22–0.71 mg/dL) for Farawave, 0.40 mg/dL (95% CI, 0.09–0.73 mg/dL) for Pulseselect, and 0.10 mg/dL (95% CI, 0.02–0.19 mg/dL) for Sphere-9. CONCLUSIONS: PFA-induced hemolysis is common, with different PFA technologies exhibiting variable degrees of hemolysis, lower with the focal PFA catheter Sphere-9 when compared with single-shot PFA catheters.
- Open Access
- 30 October 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (11)
Assessment of temperature dynamics in pulsed field ablation with a variable-loop circular catheter: a comparative analysis of waveform configurations and irrigation rates in specimens of bovine ventricular myocardium
Aims: Pulsed Field ablation (PFA) is a non-thermal ablation modality with functional myocardial sparing. Recent evidence suggests that clinically used PFA systems may produce non-negligible thermal effects, particularly at the tissue-catheter interface, potentially increasing the risk of thrombo-embolic complications. This study sought to characterize the temperature dynamics of two PFA pulse waveforms, delivered using a variable-loop circular catheter, under different irrigation conditions. Methods and results: In total, 132 ablations were performed on 31 bovine myocardial tissue specimens, using Sequence_1 and Sequence_2 at two different irrigation rates—4 and 30 mL/min. Maximum temperatures and their rise from baseline were measured at the tissue surface, and at 3 and 7 mm depths, across different ablation conditions. Sequence_1 at 4 mL/min produced the highest surface temperature (56.4°C [54.9–58.4]) and temperature rise (ΔT: 19.4°C [17.9–21.4]). Sequence_2 at 30 mL/min showed the most favourable thermal profile, with significantly lower surface temperatures (40.8°C [37.9–43.0], ΔT: 3.8°C [0.9–6.0], P < 0.0001). At 3 mm depth, temperature increases were reduced for all settings, but remained highest with Sequence_1 at 4 mL/min (42.5°C, ΔT: 5.5°C). At 7 mm depth, temperatures remained close to baseline. Both waveform and irrigation optimization independently and synergistically reduced tissue heating, with the Sequence_2 at 30 mL/min achieving the lowest thermal load at all depths. Conclusion: This study confirms that PFA can induce relevant thermal effects, especially at the tissue interface. However, waveform optimization and active cooling significantly mitigate these effects. Such strategies to minimize thermal effects should be implemented in clinical practice to enhance procedural safety.
- 30 October 2025
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (11)
Open AccessAssessment of temperature dynamics in pulsed field ablation with a variable-loop circular catheter: a comparative analysis of waveform configurations and irrigation rates in specimens of bovine ventricular myocardium
Aims: Pulsed Field ablation (PFA) is a non-thermal ablation modality with functional myocardial sparing. Recent evidence suggests that clinically used PFA systems may produce non-negligible thermal effects, particularly at the tissue-catheter interface, potentially increasing the risk of thrombo-embolic complications. This study sought to characterize the temperature dynamics of two PFA pulse waveforms, delivered using a variable-loop circular catheter, under different irrigation conditions. Methods and results: In total, 132 ablations were performed on 31 bovine myocardial tissue specimens, using Sequence_1 and Sequence_2 at two different irrigation rates—4 and 30 mL/min. Maximum temperatures and their rise from baseline were measured at the tissue surface, and at 3 and 7 mm depths, across different ablation conditions. Sequence_1 at 4 mL/min produced the highest surface temperature (56.4°C [54.9–58.4]) and temperature rise (ΔT: 19.4°C [17.9–21.4]). Sequence_2 at 30 mL/min showed the most favourable thermal profile, with significantly lower surface temperatures (40.8°C [37.9–43.0], ΔT: 3.8°C [0.9–6.0], P < 0.0001). At 3 mm depth, temperature increases were reduced for all settings, but remained highest with Sequence_1 at 4 mL/min (42.5°C, ΔT: 5.5°C). At 7 mm depth, temperatures remained close to baseline. Both waveform and irrigation optimization independently and synergistically reduced tissue heating, with the Sequence_2 at 30 mL/min achieving the lowest thermal load at all depths. Conclusion: This study confirms that PFA can induce relevant thermal effects, especially at the tissue interface. However, waveform optimization and active cooling significantly mitigate these effects. Such strategies to minimize thermal effects should be implemented in clinical practice to enhance procedural safety.
- 17 October 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (1) , 108-115
Prevalence of Peridevice Leak in Patients With Left Atrial Appendage-Occlusion vs Without Electrically Isolated Left Atrial Appendage
- 17 October 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (1) , 108-115
Prevalence of Peridevice Leak in Patients With Left Atrial Appendage-Occlusion vs Without Electrically Isolated Left Atrial Appendage
- 4 October 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (12) , 2742-2753
Impact of Device Compression on Peridevice Leak After Left Atrial Appendage Closure
- 4 October 2025
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 11 (12) , 2742-2753
Impact of Device Compression on Peridevice Leak After Left Atrial Appendage Closure
- 27 September 2025
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 19 (1) , 1-5
Avoiding Non-Traditional Ablation Risks with Pulse-Field Ablation for Atrial Fibrillation
- 27 September 2025
- Published by Springer Nature in Current Cardiovascular Risk Reports
- Vol. 19 (1) , 1-5
Avoiding Non-Traditional Ablation Risks with Pulse-Field Ablation for Atrial Fibrillation